This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Baxter International Inc.
Drug Names(s): Esmolol
Description: Brevibloc is a beta 1-selective (cardioselective) blocking agent with a short duration of action (elimination half-life of approximately 9 minutes). Beta blockers block the action of epinephrine and norepinephrine. As a result, they slow the heart rate, and slow conduction through the AV node between the atria (upper chambers) and ventricles (lower chambers) of the heart.
Pink Sheet In Brief: Sanofi Winthrop & Ohmeda
Pink Sheet BOC Health Care
Pink Sheet Cardio-renal drugs advisory cmte.
Additional information available to subscribers only: